About Autolus
Autolus is a company based in London (United Kingdom) founded in 2015.. Autolus has raised $181.37 million across 5 funding rounds from investors including BioNTech, Blackstone and Syncona. The company has 647 employees as of December 31, 2024. Autolus operates in a competitive market with competitors including Moderna, Senti Biosciences, Horizon Therapeutics, Forge Biologics and argenx, among others.
- Headquarter London, United Kingdom
- Employees 647 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Autolus Therapeutics Plc Sponsored Adr
-
Annual Revenue
$10.12 M496.25as on Dec 31, 2024
-
Net Profit
$-220.75 M-5.94as on Dec 31, 2024
-
EBITDA
$-213.46 M-13.27as on Dec 31, 2024
-
Total Equity Funding
$181.37 M (USD)
in 5 rounds
-
Latest Funding Round
$200 M (USD), Post-IPO
Feb 08, 2024
-
Investors
BioNTech
& 5 more
-
Employee Count
647
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Autolus
Autolus is a publicly listed company on the NASDAQ with ticker symbol AUTL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Leadership Team
31 people
Software Development Team
27 people
Senior Team
22 people
Product Management Team
12 people
Finance and Accounting
7 people
Operations Team
6 people
Research Team
5 people
Human Resources and Administration
5 people
Unlock access to complete
Funding Insights of Autolus
Autolus has successfully raised a total of $181.37M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $200 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $200.0M
-
First Round
First Round
(22 Jan 2015)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Post-IPO - Autolus | Valuation |
investors |
|
| Nov, 2021 | Amount | Post-IPO - Autolus | Valuation |
investors |
|
| Sep, 2017 | Amount | Series C - Autolus | Valuation | Syncona |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Autolus
Autolus has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include BioNTech, Blackstone and Syncona. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Healthcare investments are managed via private equity by Syncona.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Autolus
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Autolus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Autolus Comparisons
Competitors of Autolus
Autolus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Senti Biosciences, Horizon Therapeutics, Forge Biologics and argenx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Autolus
Frequently Asked Questions about Autolus
When was Autolus founded?
Autolus was founded in 2015.
Where is Autolus located?
Autolus is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Autolus?
Christian Martin Itin is the current CEO of Autolus.
Is Autolus a funded company?
Autolus is a funded company, having raised a total of $181.37M across 5 funding rounds to date. The company's 1st funding round was a Series C of $80M, raised on Jan 22, 2015.
How many employees does Autolus have?
As of Dec 31, 2024, the latest employee count at Autolus is 647.
What is the annual revenue of Autolus?
Annual revenue of Autolus is $10.12M as on Dec 31, 2024.
What does Autolus do?
Autolus was founded in 2015 in London, United Kingdom, within the biotechnology sector. Engineered T-cell therapies are developed and commercialized by the company, targeting hematological and solid tumors. A pipeline of CAR T-cell products is advanced using proprietary targets, constructs, and technologies. Emphasis is placed on immunotherapy applications for cancer and auto-immune conditions.
Who are the top competitors of Autolus?
Autolus's top competitors include Moderna, argenx and Forge Biologics.
Is Autolus publicly traded?
Yes, Autolus is publicly traded on NASDAQ under the ticker symbol AUTL.
Who are Autolus's investors?
Autolus has 6 investors. Key investors include BioNTech, Blackstone, Syncona, Arix Bioscience, and Woodford Investment Management.
What is Autolus's ticker symbol?
The ticker symbol of Autolus is AUTL on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.